Lexicon Pharmaceuticals
LXRX
#6646
Rank
โ‚ฌ0.75 B
Marketcap
1,69ย โ‚ฌ
Share price
0.54%
Change (1 day)
25.41%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): -0,12ย โ‚ฌ

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -0,13ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,13ย โ‚ฌ an increase over its 2024 EPS that were of -0,58ย โ‚ฌ.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,12ย โ‚ฌ-3.59%
2025-0,13ย โ‚ฌ-78.13%
2024-0,58ย โ‚ฌ-20%
2023-0,72ย โ‚ฌ31.15%
2022-0,55ย โ‚ฌ-0%
2021-0,55ย โ‚ฌ10.91%
2020-0,50ย โ‚ฌ-145.08%
20191,10ย โ‚ฌ-206.09%
2018-1,04ย โ‚ฌ-5.74%
2017-1,10ย โ‚ฌ-10.95%
2016-1,24ย โ‚ฌ2640%
2015-0,04514ย โ‚ฌ-96.34%
2014-1,23ย โ‚ฌ-2.53%
2013-1,26ย โ‚ฌ-9.09%
2012-1,39ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
17,15ย โ‚ฌ-13,664.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
5,32ย โ‚ฌ-4,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
42,42ย โ‚ฌ-33,657.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-4,69ย โ‚ฌ 3,607.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
2,34ย โ‚ฌ-1,950.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-0,01806ย โ‚ฌ-85.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-0,68ย โ‚ฌ 435.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-0,08126ย โ‚ฌ-35.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-26,45ย โ‚ฌ 20,821.43%๐Ÿ‡บ๐Ÿ‡ธ USA